Approval · Notice of Compliance 28958 · 2022
RIVA-HYDROXYUREA: Notice of Compliance 28958
Issued September 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28958
- Date
- September 14, 2022
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- HYDREA (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIVA-HYDROXYUREA | 02530260 | Marketed |
Medicinal ingredients
- HYDROXYUREA 500 MG per CAP